This article is more than 5 years old. Information may no longer be current.
Top stories in gastroenterology: FDA revises draft guidance on clinical evaluation of gastroparesis drugs, inflammatory bowel disease increases myocardial infarction risk
Click Here to Manage Email Alerts
Among the top stories in gastroenterology last week were the FDA’s revision of draft guidance on the clinical evaluation of gastroparesis drugs and a study that found patients with Crohn’s disease are at higher risk for myocardial infarction than the general population.
Other popular stories include research that determined patients with ulcerative colitis who smoke or who have never smoked experience similar outcomes, a study that indicated diarrhea- and constipation-predominant irritable bowel syndrome impact patients’ lives differently and research that suggested non-alcoholic steatohepatitis-related cirrhosis may increase risk for recurrent Clostridium difficile infections. - by Melissa Webb
FDA revises draft guidance on clinical evaluation of gastroparesis drugs
The FDA has provided a revised version of the draft guidance on trial designs and endpoints for clinical evaluation of gastroparesis medication. Read more.
Patients with inflammatory bowel disease at increased risk for myocardial infarction
Patients with Crohn’s disease are at higher risk for myocardial infarction than the general population, according to study results. Read more.
Smoking has no beneficial impact on ulcerative colitis outcomes
Patients with ulcerative colitis who smoke or have never smoked experience similar outcomes in terms of therapies they use, hospitalization and surgery, according to study results. Read more.
Patients with diarrhea- , constipation-predominant irritable bowel syndrome find their lives impacted in different ways
Although patients with diarrhea- and constipation-predominant irritable bowel syndrome tend to find their condition equally bothersome, they find their lives impacted in different ways, according to survey results. Read more.
Cirrhosis etiology may increase risk for recurrent C. difficile infection
Non-alcoholic steatohepatitis-related cirrhosis may be an independent risk factor for recurrent Clostridium difficile infections. Read more.